SCHEMBL14073608

SCHEMBL14073608

O=C1COc2ccc(NC(=O)c3ccc4ncccc4c3)cc2N1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.57
▸ POLB P06746 3/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ HSF1 Q00613 1/20 0.57
▸ KMT2A Q03164 2/20 0.56
▸ MALT1 Q9UDY8 2/20 0.53
▸ PABPC1 P11940 1/20 0.53
▸ NPC1 O15118 5/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ TRPV1 Q8NER1 2/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ SENP8 Q96LD8 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ SENP6 Q9GZR1 1/20 0.51
▸ GAA P10253 2/20 0.49
▸ TP53 P04637 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ PLK1 P53350 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14073886 0.92 CYP3A4 (0.55) MAPTPOLBALDH1A1HSF1KMT2A
SCHEMBL14073656 0.88 MAPT (0.64) MAPTPOLBALDH1A1KMT2AMALT1
SCHEMBL14073579 0.87 KMT2A (0.60) MAPTPOLBALDH1A1KMT2AMALT1
SCHEMBL8192718 0.84 ALDH1A1 (0.77) MAPTPOLBALDH1A1KMT2ATRPV1
SCHEMBL14073359 0.83 TSHR (0.63) MAPTALDH1A1GAAPLK1
SCHEMBL14073610 0.82 KMT2A (0.67) MAPTPOLBALDH1A1KMT2AMALT1
SCHEMBL14073652 0.81 ALDH1A1 (0.61) MAPTPOLBALDH1A1KMT2ANPC1
SCHEMBL14073031 0.81 ALDH1A1 (0.69) MAPTPOLBALDH1A1KMT2ANPC1
SCHEMBL22284873 0.80 CYP3A4 (0.58) MAPTPOLBALDH1A1HSF1KMT2A
SCHEMBL14073571 0.80 ALDH1A1 (0.63) MAPTPOLBALDH1A1KMT2AMALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221093-A1 Metalloprotease inhibitors containing a heterocyclic moiety ALANTOS PHARMACEUTICALS HOLDING, INC. 2008-09-11 — — US disclosed
US-20080221093-A1 Metalloprotease inhibitors containing a heterocyclic moiety ALANTOS PHARMACEUTICALS HOLDING, INC. 2008-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221093-A1 Metalloprotease inhibitors containing a heterocyclic moiety MMP12, MMP13, MMP25 MAPT 3986/4885POLB 2906/4885ALDH1A1 714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback